Human	O
cytomegalovirus	O
induces	O
interleukin-8	B-protein
production	O
by	O
a	O
human	B-cell_line
monocytic	I-cell_line
cell	I-cell_line
line	I-cell_line
,	O
THP-1	B-cell_line
,	O
through	O
acting	O
concurrently	O
on	O
AP-1-	B-DNA
and	I-DNA
NF-kappaB-binding	I-DNA
sites	I-DNA
of	O
the	O
interleukin-8	B-DNA
gene	I-DNA
.	O

Cytomegalovirus	O
(	O
CMV	O
)	O
infection	O
induced	O
interleukin-8	B-protein
(	O
IL-8	B-protein
)	O
gene	O
transcription	O
in	O
a	O
human	B-cell_line
monocytic	I-cell_line
cell	I-cell_line
line	I-cell_line
,	O
THP-1	B-cell_line
cells	I-cell_line
,	O
leading	O
to	O
IL-8	B-protein
secretion	O
.	O

The	O
functional	O
analysis	O
of	O
the	O
IL-8	B-DNA
gene	I-DNA
revealed	O
that	O
both	O
AP-1-	B-DNA
and	I-DNA
NF-kappaB	I-DNA
factor-binding	I-DNA
elements	I-DNA
were	O
involved	O
in	O
conferring	O
the	O
responsiveness	O
to	O
CMV	O
.	O

Moreover	O
,	O
electrophoretic	O
mobility	O
shift	O
assays	O
demonstrated	O
that	O
CMV	O
induced	O
the	O
formation	O
of	O
NF-kappaB	B-protein
and	O
AP-1	B-protein
complexes	I-protein
.	O

These	O
results	O
suggest	O
that	O
CMV	O
activates	O
these	O
transcriptional	B-protein
factors	I-protein
,	O
resulting	O
in	O
IL-8	B-protein
gene	O
expression	O
.	O

JOURNAL	NULL
OF	NULL
ViRoLOGY	NULL
,	NULL
July	NULL
1997	NULL
,	NULL
p.	NULL
5692-5695	NULL
0022-538X	NULL
,	NULL
/97/	NULL
$	NULL
04.00+0	NULL
Copyright	NULL
©	NULL
1997	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

71	NULL
,	NULL
No	NULL
.	NULL

7	NULL
Human	NULL
Cytomegalovirus	NULL
Induces	NULL
Interleukin-8	NULL
Production	NULL
by	NULL
a	NULL
Human	NULL
Monocytic	NULL
Cell	NULL
Line	NULL
,	NULL
THP-1	NULL
,	NULL
through	NULL
Acting	NULL
Concurrently	NULL
on	NULL
AP-1-	NULL
and	NULL
NF-	NULL
«	NULL
xB-Binding	NULL
Sites	NULL
of	NULL
the	NULL
Interleukin-8	NULL
Gene	NULL
TSUGIYA	NULL
MURAYAMA	NULL
,	NULL
**	NULL
YOSHIRO	NULL
OHARA	NULL
,	NULL
*	NULL
MASATSUGU	NULL
OBUCHI	NULL
,	NULL
'	NULL
KHALLD	NULL
S.	NULL
A.	NULL
KHABAR	NULL
,	NULL
*	NULL
HIDEMITSU	NULL
HIGASHI	NULL
,	NULL
*	NULL
NAOFUMI	NULL
MUKAIDA	NULL
,	NULL
*	NULL
anp	NULL
KOUJI	NULL
MATSUSHIMA*	NULL
Department	NULL
of	NULL
Microbiology	NULL
,	NULL
Kanazawa	NULL
Medical	NULL
University	NULL
,	NULL
Uchinada	NULL
,	NULL
Ishikawa	NULL
920-02	NULL
,	NULL
Department	NULL
of	NULL
Pharmacology	NULL
,	NULL
Cancer	NULL
Research	NULL
Institute	NULL
,	NULL
Kanazawa	NULL
University	NULL
,	NULL
Kanazawa	NULL
920	NULL
,	NULL
°	NULL
and	NULL
Department	NULL
of	NULL
Molecular	NULL
Preventive	NULL
Medicine	NULL
,	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
University	NULL
of	NULL
Tokyo	NULL
,	NULL
Bunkyo	NULL
,	NULL
Tokyo	NULL
113	NULL
,	NULL
``	NULL
Japan	NULL
,	NULL
and	NULL
Biological	NULL
and	NULL
Medical	NULL
Research	NULL
Department	NULL
,	NULL
King	NULL
Faisal	NULL
Specialist	NULL
Hospital	NULL
and	NULL
Research	NULL
Center	NULL
,	NULL
Riyadh	NULL
11211	NULL
,	NULL
Saudi	NULL
Arabia	NULL
``	NULL
Received	NULL
23	NULL
December	NULL
1996/Accepted	NULL
1	NULL
April	NULL
1997	NULL
Cytomegalovirus	NULL
(	NULL
CMV	NULL
)	NULL
infection	NULL
induced	NULL
interleukin-8	NULL
(	NULL
IL-8	NULL
)	NULL
gene	NULL
transcription	NULL
in	NULL
a	NULL
human	NULL
monocytic	NULL
cell	NULL
line	NULL
,	NULL
THP-1	NULL
cells	NULL
,	NULL
leading	NULL
to	NULL
IL-8	NULL
secretion	NULL
.	NULL

The	NULL
functional	NULL
analysis	NULL
of	NULL
the	NULL
IL-8	NULL
gene	NULL
revealed	NULL
that	NULL
both	NULL
AP-1-and	NULL
NF-B	NULL
factor-binding	NULL
elements	NULL
were	NULL
involved	NULL
in	NULL
conferring	NULL
the	NULL
responsiveness	NULL
to	NULL
CMV	NULL
.	NULL

Moreover	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
demonstrated	NULL
that	NULL
CMV	NULL
induced	NULL
the	NULL
formation	NULL
of	NULL
and	NULL
AP-1	NULL
complexes	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
CMV	NULL
activates	NULL
these	NULL
transcriptional	NULL
factors	NULL
,	NULL
resulting	NULL
in	NULL
IL-8	NULL
gene	NULL
expression	NULL
.	NULL

Cytomegalovirus	NULL
(	NULL
CMV	NULL
)	NULL
is	NULL
a	NULL
ubiquitous	NULL
herpesvirus	NULL
infecting	NULL
50	NULL
to	NULL
90	NULL
%	NULL
of	NULL
normal	NULL
adults	NULL
and	NULL
is	NULL
a	NULL
major	NULL
cause	NULL
of	NULL
morbidity	NULL
and	NULL
mortality	NULL
in	NULL
immunocompromised	NULL
individuals	NULL
(	NULL
1	NULL
)	NULL
.	NULL

The	NULL
progression	NULL
of	NULL
CMV	NULL
infection	NULL
is	NULL
related	NULL
to	NULL
a	NULL
complex	NULL
interrelation	NULL
of	NULL
virus	NULL
replication	NULL
with	NULL
the	NULL
host	NULL
immune	NULL
system	NULL
,	NULL
including	NULL
soluble	NULL
and	NULL
cellular	NULL
factors	NULL
.	NULL

Evidence	NULL
is	NULL
accumulating	NULL
that	NULL
a	NULL
chemotactic	NULL
cytokine	NULL
(	NULL
chemokine	NULL
)	NULL
,	NULL
interleukin-8	NULL
(	NULL
IL-8	NULL
)	NULL
,	NULL
is	NULL
essentially	NULL
involved	NULL
in	NULL
neutrophil-mediated	NULL
tissue	NULL
injury	NULL
(	NULL
5	NULL
,	NULL
13	NULL
,	NULL
19	NULL
)	NULL
.	NULL

IL-8	NULL
enhanced	NULL
the	NULL
production	NULL
of	NULL
infectious	NULL
virions	NULL
and	NULL
the	NULL
replication	NULL
of	NULL
CMV	NULL
in	NULL
human	NULL
embryonic	NULL
lung	NULL
fibroblasts	NULL
,	NULL
and	NULL
CMV	NULL
selectively	NULL
induced	NULL
IL-8	NULL
receptor	NULL
type	NULL
A	NULL
(	NULL
CXCR1	NULL
)	NULL
transcript	NULL
in	NULL
the	NULL
same	NULL
cells	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Although	NULL
mono-cytes/macrophages	NULL
are	NULL
the	NULL
predominant	NULL
type	NULL
of	NULL
cells	NULL
harboring	NULL
CMV	NULL
(	NULL
2	NULL
)	NULL
and	NULL
can	NULL
produce	NULL
large	NULL
amounts	NULL
of	NULL
IL-8	NULL
in	NULL
response	NULL
to	NULL
various	NULL
stimuli	NULL
(	NULL
6	NULL
)	NULL
,	NULL
it	NULL
remains	NULL
to	NULL
be	NULL
investigated	NULL
whether	NULL
CMV	NULL
infection	NULL
can	NULL
induce	NULL
IL-8	NULL
production	NULL
in	NULL
human	NULL
mono-cytes/macrophages	NULL
.	NULL

Hence	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
effects	NULL
of	NULL
CMV	NULL
infection	NULL
on	NULL
IL-8	NULL
production	NULL
,	NULL
using	NULL
a	NULL
human	NULL
monocytic	NULL
cell	NULL
line	NULL
,	NULL
THP-1	NULL
(	NULL
24	NULL
)	NULL
,	NULL
in	NULL
which	NULL
infection	NULL
is	NULL
aborted	NULL
at	NULL
the	NULL
stage	NULL
of	NULL
CMV	NULL
immediate-early	NULL
(	NULL
IE	NULL
)	NULL
gene	NULL
expression	NULL
(	NULL
17	NULL
,	NULL
20	NULL
)	NULL
.	NULL

The	NULL
Towne	NULL
strain	NULL
of	NULL
CMV	NULL
(	NULL
4	NULL
)	NULL
was	NULL
propagated	NULL
on	NULL
human	NULL
embryonal	NULL
lung	NULL
fibroblast	NULL
cells	NULL
,	NULL
MRC-5	NULL
(	NULL
8	NULL
)	NULL
,	NULL
and	NULL
was	NULL
titrated	NULL
by	NULL
a	NULL
standard	NULL
plaque	NULL
assay	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
26	NULL
)	NULL
.	NULL

In	NULL
some	NULL
experiments	NULL
,	NULL
CMV	NULL
was	NULL
irradiated	NULL
with	NULL
UV	NULL
light	NULL
(	NULL
100	NULL
V	NULL
,	NULL
15	NULL
W	NULL
)	NULL
for	NULL
10	NULL
min	NULL
at	NULL
a	NULL
distance	NULL
of	NULL
10	NULL
em	NULL
.	NULL

A	NULL
human	NULL
monocytic	NULL
cell	NULL
line	NULL
,	NULL
THP-1	NULL
(	NULL
24	NULL
)	NULL
,	NULL
was	NULL
infected	NULL
with	NULL
the	NULL
Towne	NULL
strain	NULL
of	NULL
CMV	NULL
at	NULL
the	NULL
indicated	NULL
multiplicity	NULL
of	NULL
infection	NULL
(	NULL
MOI	NULL
)	NULL
and	NULL
was	NULL
cultured	NULL
thereafter	NULL
for	NULL
the	NULL
times	NULL
indicated	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

IL-8	NULL
levels	NULL
in	NULL
the	NULL
culture	NULL
supernatants	NULL
were	NULL
determined	NULL
by	NULL
an	NULL
enzyme-linked	NULL
immunosorbent	NULL
assay	NULL
specific	NULL
for	NULL
human	NULL
IL-8	NULL
(	NULL
11	NULL
)	NULL
.	NULL

Ten	NULL
micrograms	NULL
of	NULL
total	NULL
cellular	NULL
RNA	NULL
extracted	NULL
from	NULL
infected	NULL
THP-1	NULL
cells	NULL
was	NULL
processed	NULL
for	NULL
Northern	NULL
blotting	NULL
by	NULL
using	NULL
radiolabeled	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
Department	NULL
of	NULL
Microbiology	NULL
,	NULL
Kanazawa	NULL
Medical	NULL
University	NULL
,	NULL
1-1	NULL
Daigaku	NULL
,	NULL
Uchinada	NULL
,	NULL
Ishikawa	NULL
920-02	NULL
,	NULL
Japan	NULL
.	NULL

Phone	NULL
:	NULL
81-762-86-2211	NULL
.	NULL

Fax	NULL
:	NULL
81-762-86-3961	NULL
.	NULL

5692	NULL
human	NULL
IL-8	NULL
or	NULL
B-actin	NULL
cDNA	NULL
as	NULL
a	NULL
probe	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Deleted	NULL
-flanking	NULL
regions	NULL
of	NULL
the	NULL
IL-8	NULL
gene	NULL
were	NULL
subcloned	NULL
into	NULL
a	NULL
firefly	NULL
luciferase	NULL
expression	NULL
vector	NULL
(	NULL
6	NULL
,	NULL
16	NULL
)	NULL
.	NULL

Site-directed	NULL
mutagenesis	NULL
of	NULL
the	NULL
IL-8	NULL
AP-1	NULL
,	NULL
NF-IL-6	NULL
,	NULL
and	NULL
«	NULL
B-like	NULL
sites	NULL
in	NULL
the	NULL
-133-luciferase	NULL
plasmid	NULL
was	NULL
carried	NULL
out	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
15	NULL
)	NULL
.	NULL

Two	NULL
million	NULL
THP	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
plasmid	NULL
DNA	NULL
by	NULL
the	NULL
DEAE-dextran	NULL
method	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Transfected	NULL
cells	NULL
were	NULL
then	NULL
divided	NULL
into	NULL
two	NULL
portions	NULL
and	NULL
incubated	NULL
for	NULL
24	NULL
h	NULL
at	NULL
a	NULL
density	NULL
of	NULL
4	NULL
X	NULL
10°	NULL
cells/ml	NULL
.	NULL

Thereafter	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
further	NULL
cultured	NULL
with	NULL
or	NULL
without	NULL
CMV	NULL
(	NULL
MOI	NULL
,	NULL
1	NULL
)	NULL
or	NULL
lipo-polysaccharide	NULL
(	NULL
LPS	NULL
)	NULL
(	NULL
Escherichia	NULL
coli	NULL
055	NULL
B5	NULL
LPS	NULL
;	NULL
Difco	NULL
Lab-oratories	NULL
,	NULL
Detroit	NULL
,	NULL
Mich.	NULL
)	NULL
for	NULL
24	NULL
h.	NULL
After	NULL
protein	NULL
concentrations	NULL
were	NULL
determined	NULL
with	NULL
a	NULL
protein	NULL
assay	NULL
kit	NULL
(	NULL
Pierce	NULL
,	NULL
Rockford	NULL
,	NULL
III	NULL
.	NULL
)	NULL

using	NULL
bovine	NULL
serum	NULL
albumin	NULL
as	NULL
a	NULL
standard	NULL
,	NULL
luciferase	NULL
activities	NULL
in	NULL
10	NULL
pug	NULL
of	NULL
cell	NULL
lysates	NULL
were	NULL
determined	NULL
with	NULL
a	NULL
Pica	NULL
Gene	NULL
kit	NULL
(	NULL
Toyo	NULL
Ink	NULL
Inc.	NULL
,	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
and	NULL
a	NULL
Lumat	NULL
(	NULL
Berthold	NULL
,	NULL
Germany	NULL
)	NULL
model	NULL
LB950	NULL
luminometer	NULL
.	NULL

Nuclear	NULL
proteins	NULL
were	NULL
extracted	NULL
from	NULL
THP-1	NULL
cells	NULL
infected	NULL
with	NULL
CMV	NULL
(	NULL
MOL	NULL
,	NULL
1	NULL
)	NULL
for	NULL
3	NULL
h	NULL
according	NULL
to	NULL
the	NULL
method	NULL
described	NULL
by	NULL
Dignam	NULL
et	NULL
al	NULL
.	NULL

(	NULL
3	NULL
)	NULL
.	NULL

Four	NULL
micrograms	NULL
of	NULL
proteins	NULL
was	NULL
processed	NULL
for	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
using	NULL
the	NULL
AP-1-binding	NULL
site	NULL
(	NULL
-130	NULL
to	NULL
=-116	NULL
bp	NULL
;	NULL
GTGATGACTCA	NULL
GGT	NULL
)	NULL
or	NULL
xB-binding	NULL
site	NULL
(	NULL
-83	NULL
to	NULL
-68	NULL
bp	NULL
;	NULL
CGTGGAATTTC	NULL
CTCTG	NULL
)	NULL
of	NULL
the	NULL
IL-8	NULL
gene	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
6	NULL
,	NULL
12	NULL
,	NULL
16	NULL
)	NULL
.	NULL

In	NULL
some	NULL
experiments	NULL
,	NULL
nuclear	NULL
proteins	NULL
were	NULL
preincubated	NULL
with	NULL
either	NULL
a	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
oligomers	NULL
or	NULL
1	NULL
pl	NULL
of	NULL
10-fold-diluted	NULL
rabbit	NULL
antisera	NULL
against	NULL
human	NULL
c-Rel	NULL
(	NULL
22	NULL
)	NULL
,	NULL
p65	NULL
,	NULL
p50	NULL
,	NULL
and	NULL
RelB	NULL
(	NULL
18	NULL
)	NULL
before	NULL
being	NULL
loaded	NULL
onto	NULL
a	NULL
gel	NULL
.	NULL

CMV	NULL
infection	NULL
induced	NULL
THP-1	NULL
cells	NULL
to	NULL
secrete	NULL
IL-8	NULL
protein	NULL
within	NULL
1	NULL
day	NULL
,	NULL
and	NULL
the	NULL
protein	NULL
level	NULL
reached	NULL
a	NULL
plateau	NULL
on	NULL
days	NULL
3	NULL
to	NULL
5	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

The	NULL
analysis	NULL
of	NULL
the	NULL
time	NULL
soon	NULL
after	NULL
infection	NULL
demonstrated	NULL
that	NULL
IL-8	NULL
secretion	NULL
started	NULL
between	NULL
3	NULL
to	NULL
6	NULL
h	NULL
after	NULL
the	NULL
infection	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
UV-irradiated	NULL
CMV	NULL
or	NULL
virus-free	NULL
filtrates	NULL
of	NULL
CMV-infected	NULL
MRC-5	NULL
cell	NULL
culture	NULL
supernatants	NULL
induced	NULL
only	NULL
a	NULL
marginal	NULL
level	NULL
of	NULL
IL-8	NULL
secretion	NULL
until	NULL
7	NULL
days	NULL
postinfection	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

Infectious	NULL
CMV	NULL
but	NULL
not	NULL
UV-irradiated	NULL
CMV	NULL
at	NULL
an	NULL
MOI	NULL
of	NULL
0.25	NULL
to	NULL
1	NULL
induced	NULL
IL-8	NULL
Vor	NULL
.	NULL

71	NULL
,	NULL
1997	NULL
A	NULL
60	NULL
-O-	NULL
Mock	NULL
-O-	NULL
_	NULL
CMV	NULL
--	NULL
-	NULL
UV-CMV	NULL
50	NULL
1	NULL
-a-	NULL
Filtrated-CMV	NULL
mnt	NULL
IER	NULL
IL-8	NULL
conc	NULL
.	NULL

(	NULL
ng/ml	NULL
)	NULL
Culture	NULL
time	NULL
(	NULL
days	NULL
)	NULL
(	NULL
1\2	NULL
34	NULL
5	NULL
06	NULL
,	NULL
7	NULL
?	NULL

8	NULL
9	NULL
O	NULL
@	NULL
@	NULL
w	NULL
U	NULL
to	NULL
--	NULL
|-s	NULL
wo	NULL
an	NULL
Whit	NULL
-	NULL
-a	NULL
Waa	NULL
5258	NULL
``	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Kinetics	NULL
of	NULL
IL-8	NULL
production	NULL
by	NULL
THP-1	NULL
cells	NULL
.	NULL

THP-1	NULL
cells	NULL
(	NULL
10°	NULL
cells/2	NULL
ml	NULL
)	NULL
were	NULL
infected	NULL
with	NULL
CMV	NULL
at	NULL
an	NULL
MOI	NULL
of	NULL
1	NULL
(	NULL
CMV	NULL
)	NULL
or	NULL
an	NULL
equivalent	NULL
amount	NULL
of	NULL
UV-irradiated	NULL
CMV	NULL
(	NULL
UV-CMV	NULL
)	NULL
,	NULL
were	NULL
mock	NULL
infected	NULL
(	NULL
Mock	NULL
)	NULL
,	NULL
or	NULL
were	NULL
stimulated	NULL
with	NULL
virus-free	NULL
CMV-infected	NULL
MRC-5	NULL
cell	NULL
culture	NULL
supernatants	NULL
(	NULL
Filtrated-CMV	NULL
)	NULL
or	NULL
LPS	NULL
(	NULL
100	NULL
ng/m	NULL
!	NULL
)	NULL

(	NULL
LPS	NULL
)	NULL
.	NULL

Culture	NULL
supernatants	NULL
were	NULL
collected	NULL
at	NULL
the	NULL
indicated	NULL
times	NULL
,	NULL
and	NULL
IL-8	NULL
content	NULL
of	NULL
the	NULL
supernatants	NULL
(	NULL
IL-8	NULL
conc	NULL
.	NULL
)	NULL

was	NULL
measured	NULL
by	NULL
enzyme-linked	NULL
immunosorbent	NULL
assay	NULL
.	NULL

Data	NULL
are	NULL
expressed	NULL
as	NULL
means	NULL
+	NULL
standard	NULL
errors	NULL
(	NULL
error	NULL
bars	NULL
)	NULL
calculated	NULL
from	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Northern	NULL
blots	NULL
of	NULL
total	NULL
RNA	NULL
extracted	NULL
from	NULL
CMV-infected	NULL
THP-1	NULL
cells	NULL
.	NULL

Total	NULL
RNAs	NULL
were	NULL
extracted	NULL
from	NULL
THP-1	NULL
cells	NULL
at	NULL
6	NULL
h	NULL
(	NULL
lanes	NULL
1	NULL
,	NULL
4	NULL
,	NULL
and	NULL
7	NULL
)	NULL
,	NULL
12	NULL
h	NULL
(	NULL
lanes	NULL
2	NULL
,	NULL
5	NULL
,	NULL
and	NULL
8	NULL
)	NULL
,	NULL
and	NULL
48	NULL
h	NULL
(	NULL
lanes	NULL
3	NULL
,	NULL
6	NULL
,	NULL
and	NULL
9	NULL
)	NULL
after	NULL
mock	NULL
infection	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
3	NULL
)	NULL
,	NULL
LPS	NULL
(	NULL
100	NULL
ng/m	NULL
!	NULL
)	NULL

stimulation	NULL
(	NULL
lanes	NULL
4	NULL
to	NULL
6	NULL
)	NULL
,	NULL
or	NULL
CMV	NULL
(	NULL
MOL	NULL
,	NULL
1	NULL
)	NULL
infection	NULL
(	NULL
lanes	NULL
7	NULL
to	NULL
9	NULL
)	NULL
.	NULL

Northern	NULL
blotting	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
the	NULL
text	NULL
.	NULL

production	NULL
from	NULL
THP-1	NULL
cells	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
infectious	NULL
virus	NULL
is	NULL
required	NULL
for	NULL
IL-8	NULL
production	NULL
.	NULL

Human	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
(	NULL
MNC	NULL
)	NULL
also	NULL
produced	NULL
threefold	NULL
more	NULL
IL-8	NULL
NOTES	NULL
-	NULL
5693	NULL
at	NULL
5	NULL
days	NULL
after	NULL
CMV	NULL
infection	NULL
than	NULL
did	NULL
mock-infected	NULL
cells	NULL
(	NULL
CMV-infected	NULL
cells	NULL
,	NULL
33	NULL
+	NULL
3.8	NULL
ng/ml	NULL
;	NULL
mock-infected	NULL
cells	NULL
,	NULL
10	NULL
+	NULL
1.8	NULL
ng/ml	NULL
[	NULL
means	NULL
+	NULL
standard	NULL
errors	NULL
]	NULL
)	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
demonstrated	NULL
that	NULL
CMV	NULL
infection	NULL
but	NULL
not	NULL
mock	NULL
infection	NULL
induced	NULL
IL-8	NULL
mRNA	NULL
expression	NULL
in	NULL
THP-1	NULL
cells	NULL
from	NULL
6	NULL
to	NULL
48	NULL
h	NULL
after	NULL
infection	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

An	NULL
analysis	NULL
of	NULL
the	NULL
time	NULL
soon	NULL
after	NULL
infection	NULL
showed	NULL
that	NULL
IL-8	NULL
mRNA	NULL
expression	NULL
started	NULL
rapidly	NULL
,	NULL
within	NULL
0.5	NULL
h	NULL
after	NULL
infection	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

CMV	NULL
as	NULL
well	NULL
as	NULL
LPS	NULL
greatly	NULL
increased	NULL
the	NULL
luciferase	NULL
activity	NULL
in	NULL
THP-1	NULL
cells	NULL
transfected	NULL
with	NULL
-546	NULL
or	NULL
-133-luciferase	NULL
vectors	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

However	NULL
,	NULL
LPS	NULL
but	NULL
not	NULL
CMV	NULL
infection	NULL
significantly	NULL
increased	NULL
the	NULL
luciferase	NULL
activities	NULL
in	NULL
cells	NULL
transfected	NULL
with	NULL
-98-luciferase	NULL
vector	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
minimally	NULL
essential	NULL
elements	NULL
for	NULL
IL-8	NULL
gene	NULL
regulation	NULL
by	NULL
CMV	NULL
infection	NULL
are	NULL
present	NULL
in	NULL
the	NULL
5	NULL
'	NULL
region	NULL
spanning	NULL
downstream	NULL
from	NULL
-133	NULL
bp	NULL
.	NULL

This	NULL
region	NULL
contains	NULL
three	NULL
cis	NULL
elements	NULL
,	NULL
AP-1	NULL
(	NULL
-126	NULL
to	NULL
-120	NULL
bp	NULL
)	NULL
,	NULL
NF-IL-6-like	NULL
(	NULL
-94	NULL
to	NULL
=-81	NULL
bp	NULL
)	NULL
,	NULL
and	NULL
kB-like	NULL
(	NULL
-80	NULL
to	NULL
=70	NULL
bp	NULL
)	NULL
sites	NULL
,	NULL
which	NULL
contribute	NULL
to	NULL
IL-8	NULL
gene	NULL
transcription	NULL
in	NULL
differential	NULL
manners	NULL
in	NULL
different	NULL
types	NULL
of	NULL
cells	NULL
(	NULL
6	NULL
,	NULL
12	NULL
,	NULL
16	NULL
,	NULL
27	NULL
)	NULL
.	NULL

The	NULL
mutation	NULL
of	NULL
either	NULL
the	NULL
AP-1	NULL
site	NULL
or	NULL
the	NULL
«	NULL
B-like	NULL
site	NULL
markedly	NULL
reduced	NULL
the	NULL
increase	NULL
in	NULL
the	NULL
luciferase	NULL
activity	NULL
,	NULL
whereas	NULL
mutation	NULL
of	NULL
the	NULL
NF-IL-6-like	NULL
site	NULL
only	NULL
marginally	NULL
decreased	NULL
the	NULL
inducibility	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

These	NULL
results	NULL
demonstrated	NULL
that	NULL
both	NULL
AP-1-	NULL
and	NULL
NF-	NULL
«	NULL
xB-binding	NULL
sites	NULL
were	NULL
involved	NULL
in	NULL
CMV-induced	NULL
IL-8	NULL
gene	NULL
activation	NULL
.	NULL

Nuclear	NULL
proteins	NULL
from	NULL
mock-transfected	NULL
cells	NULL
gave	NULL
rise	NULL
to	NULL
a	NULL
faint	NULL
band	NULL
when	NULL
the	NULL
NF-kB-binding	NULL
site	NULL
was	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
,	NULL
and	NULL
CMV	NULL
infection	NULL
enhanced	NULL
the	NULL
complex	NULL
formation	NULL
markedly	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

The	NULL
complex	NULL
formation	NULL
was	NULL
inhibited	NULL
by	NULL
a	NULL
corresponding	NULL
oligomer	NULL
but	NULL
not	NULL
an	NULL
unrelated	NULL
oligomer	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
,	NULL
and	NULL
the	NULL
antisera	NULL
to	NULL
p65	NULL
,	NULL
p50	NULL
,	NULL
and	NULL
c-Rel	NULL
but	NULL
not	NULL
that	NULL
to	NULL
RelB	NULL
supershifted	NULL
the	NULL
complexes	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicated	NULL
that	NULL
the	NULL
induced	NULL
complexes	NULL
were	NULL
composed	NULL
of	NULL
p65	NULL
,	NULL
p50	NULL
,	NULL
and	NULL
c-Rel	NULL
as	NULL
observed	NULL
on	NULL
complexes	NULL
in	NULL
LPS-stimulated	NULL
THP-1	NULL
cells	NULL
(	NULL
6	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
CMV	NULL
infection	NULL
also	NULL
enhanced	NULL
the	NULL
AP-1	NULL
complex	NULL
formation	NULL
better	NULL
than	NULL
mock	NULL
infection	NULL
did	NULL
,	NULL
and	NULL
the	NULL
AP-1	NULL
complexes	NULL
were	NULL
inhibited	NULL
by	NULL
a	NULL
specific	NULL
primer	NULL
but	NULL
not	NULL
by	NULL
an	NULL
unrelated	NULL
primer	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
.	NULL

The	NULL
antisera	NULL
to	NULL
c-Fos	NULL
and	NULL
to	NULL
Jun-D	NULL
diminished	NULL
and	NULL
supershifted	NULL
the	NULL
complexes	NULL
,	NULL
respec-tively	NULL
,	NULL
whereas	NULL
the	NULL
complex	NULL
formation	NULL
was	NULL
not	NULL
affected	NULL
by	NULL
the	NULL
+133	NULL
(	NULL
NF-KB	NULL
site	NULL
mutated	NULL
)	NULL
-lue	NULL
a	NULL
-133	NULL
(	NULL
NF-IL-6	NULL
site	NULL
mutated	NULL
)	NULL
-luc	NULL
Z	NULL
+133	NULL
(	NULL
AP-1	NULL
site	NULL
mutated	NULL
)	NULL
-luc	NULL
E	NULL
L	NULL
LPs	NULL
C	NULL
cmy	NULL
B	NULL
Mock	NULL
-luc	NULL
i	NULL
~133-lue	NULL
I	NULL
?	NULL

{	NULL
--	NULL
-546-luc	NULL
0	NULL
1000	NULL
2000	NULL
3000	NULL
4000	NULL
5000	NULL
6000	NULL
Relative	NULL
Light	NULL
Units	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

Determination	NULL
of	NULL
CMV-responsive	NULL
elements	NULL
in	NULL
the	NULL
IL-8	NULL
gene	NULL
.	NULL

Various	NULL
types	NULL
of	NULL
chimeric	NULL
luciferase	NULL
(	NULL
luc	NULL
)	NULL
genes	NULL
were	NULL
transiently	NULL
transfected	NULL
into	NULL
THP-1	NULL
cells	NULL
followed	NULL
by	NULL
mock	NULL
infection	NULL
(	NULL
Mock	NULL
)	NULL
,	NULL
CMV	NULL
(	NULL
MOL	NULL
,	NULL
1	NULL
)	NULL
infection	NULL
(	NULL
CMV	NULL
)	NULL
,	NULL
or	NULL
LPS	NULL
(	NULL
100	NULL
ng/m	NULL
!	NULL
)	NULL

stimulation	NULL
(	NULL
LPS	NULL
)	NULL
for	NULL
24	NULL
h	NULL
prior	NULL
to	NULL
harvesting	NULL
the	NULL
cells	NULL
for	NULL
the	NULL
luciferase	NULL
assay	NULL
.	NULL

Luciferase	NULL
activities	NULL
were	NULL
measured	NULL
as	NULL
described	NULL
in	NULL
the	NULL
text	NULL
.	NULL

The	NULL
results	NULL
are	NULL
representative	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
,	NULL
and	NULL
error	NULL
bars	NULL
indicate	NULL
standard	NULL
errors	NULL
.	NULL

5694	NULL
NOTES	NULL
A	NULL
|	NULL
4	NULL
!	NULL

5	NULL
p	NULL
*	NULL
.	NULL

i	NULL
a	NULL
B	NULL
||	NULL
1232	NULL
)	NULL
8	NULL
)	NULL
6	NULL
)	NULL
7	NULL
<	NULL
in	NULL
goo	NULL
o	NULL
>	NULL
``	NULL
AF	NULL
C	NULL
t	NULL
!	NULL

2	NULL
2	NULL
1	NULL
50	NULL
I	NULL
#	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

EMSA	NULL
with	NULL
nuclear	NULL
proteins	NULL
extracted	NULL
from	NULL
CMV-infected	NULL
THP-1	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Characterization	NULL
of	NULL
nuclear	NULL
proteins	NULL
bound	NULL
to	NULL
«	NULL
B-binding	NULL
site	NULL
of	NULL
the	NULL
IL-8	NULL
gene	NULL
.	NULL

Nuclear	NULL
proteins	NULL
were	NULL
extracted	NULL
from	NULL
THP-1	NULL
cells	NULL
at	NULL
3	NULL
h	NULL
after	NULL
mock	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
3	NULL
)	NULL
or	NULL
CMV	NULL
(	NULL
lanes	NULL
4	NULL
to	NULL
6	NULL
)	NULL
infection	NULL
.	NULL

EMSA	NULL
was	NULL
performed	NULL
on	NULL
nuclear	NULL
extracts	NULL
preincubated	NULL
with	NULL
no	NULL
reagents	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
4	NULL
)	NULL
,	NULL
an	NULL
NF-	NULL
«	NULL
B	NULL
oligomer	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
5	NULL
)	NULL
,	NULL
or	NULL
an	NULL
AP-1	NULL
probe	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
6	NULL
)	NULL
,	NULL
and	NULL
the	NULL
«	NULL
B-binding	NULL
site	NULL
of	NULL
the	NULL
IL-8	NULL
gene	NULL
was	NULL
used	NULL
as	NULL
a	NULL
labeled	NULL
probe	NULL
as	NULL
described	NULL
in	NULL
the	NULL
text	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Further	NULL
characterization	NULL
of	NULL
nuclear	NULL
proteins	NULL
bound	NULL
to	NULL
«	NULL
B-binding	NULL
site	NULL
of	NULL
the	NULL
IL-8	NULL
gene	NULL
.	NULL

Nuclear	NULL
proteins	NULL
were	NULL
extracted	NULL
from	NULL
THP-1	NULL
cells	NULL
at	NULL
3	NULL
h	NULL
after	NULL
mock	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
or	NULL
CMV	NULL
(	NULL
lanes	NULL
2	NULL
to	NULL
7	NULL
)	NULL
infection	NULL
.	NULL

EMSA	NULL
was	NULL
performed	NULL
on	NULL
nuclear	NULL
proteins	NULL
preincubated	NULL
with	NULL
no	NULL
reagents	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
oligomer	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
or	NULL
anti-p65	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
anti-p50	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
,	NULL
anti-c-Rel	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
,	NULL
or	NULL
anti-ReIB	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
antiserum	NULL
,	NULL
and	NULL
the	NULL
«	NULL
B-binding	NULL
site	NULL
of	NULL
the	NULL
IL-8	NULL
gene	NULL
was	NULL
used	NULL
as	NULL
a	NULL
labeled	NULL
probe	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Characterization	NULL
of	NULL
nuclear	NULL
proteins	NULL
bound	NULL
to	NULL
AP-1-binding	NULL
site	NULL
in	NULL
the	NULL
IL-8	NULL
gene	NULL
.	NULL

Nuclear	NULL
proteins	NULL
were	NULL
extracted	NULL
from	NULL
THP-1	NULL
cells	NULL
at	NULL
3	NULL
h	NULL
after	NULL
mock	NULL
(	NULL
lanes	NULL
2	NULL
to	NULL
4	NULL
)	NULL
or	NULL
CMV	NULL
(	NULL
lanes	NULL
5	NULL
to	NULL
7	NULL
)	NULL
infection	NULL
.	NULL

EMSA	NULL
was	NULL
performed	NULL
on	NULL
nuclear	NULL
proteins	NULL
preincubated	NULL
with	NULL
no	NULL
reagents	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
5	NULL
)	NULL
,	NULL
an	NULL
AP-1	NULL
probe	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
6	NULL
)	NULL
,	NULL
or	NULL
an	NULL
NF-	NULL
«	NULL
B	NULL
probe	NULL
(	NULL
lanes	NULL
4	NULL
and	NULL
7	NULL
)	NULL
,	NULL
and	NULL
the	NULL
AP-1-binding	NULL
site	NULL
of	NULL
the	NULL
IL-8	NULL
gene	NULL
was	NULL
used	NULL
as	NULL
a	NULL
labeled	NULL
probe	NULL
.	NULL

The	NULL
labeled	NULL
DNA	NULL
fragment	NULL
without	NULL
nuclear	NULL
proteins	NULL
was	NULL
run	NULL
in	NULL
lane	NULL
1.	NULL
antisera	NULL
to	NULL
c-Jun	NULL
and	NULL
Jun-B	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
CMV	NULL
infection	NULL
induced	NULL
a	NULL
specific	NULL
AP-1	NULL
complex	NULL
composed	NULL
mainly	NULL
of	NULL
c-Fos	NULL
and	NULL
Jun-D.	NULL
We	NULL
demonstrated	NULL
in	NULL
this	NULL
study	NULL
that	NULL
infectious	NULL
CMV	NULL
but	NULL
not	NULL
UV-irradiated	NULL
CMV	NULL
induced	NULL
a	NULL
human	NULL
monocytic	NULL
cell	NULL
line	NULL
,	NULL
THP-1	NULL
,	NULL
and	NULL
peripheral	NULL
blood	NULL
MNC	NULL
to	NULL
produce	NULL
IL-8	NULL
.	NULL

We	NULL
further	NULL
showed	NULL
that	NULL
CMV	NULL
infection	NULL
caused	NULL
IL-8	NULL
gene	NULL
transcription	NULL
in	NULL
THP-1	NULL
cells	NULL
.	NULL

IL-8	NULL
production	NULL
as	NULL
well	NULL
as	NULL
gene	NULL
transcription	NULL
can	NULL
be	NULL
augmented	NULL
by	NULL
several	NULL
soluble	NULL
mediators	NULL
,	NULL
including	NULL
J.	NULL
ViRoL	NULL
.	NULL

IL-1	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
,	NULL
and	NULL
gamma	NULL
interferon	NULL
(	NULL
gam-ma	NULL
IFN	NULL
)	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Although	NULL
CMV	NULL
could	NULL
induce	NULL
IL-1	NULL
or	NULL
tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
production	NULL
(	NULL
25	NULL
)	NULL
,	NULL
the	NULL
virus-free	NULL
CMV-infected	NULL
supernatants	NULL
failed	NULL
to	NULL
induce	NULL
IL-8	NULL
production	NULL
by	NULL
THP-1	NULL
cells	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
is	NULL
unlikely	NULL
that	NULL
CMV	NULL
infection	NULL
enhanced	NULL
IL-8	NULL
production	NULL
indirectly	NULL
by	NULL
inducing	NULL
the	NULL
production	NULL
of	NULL
these	NULL
soluble	NULL
factors	NULL
.	NULL

CMV	NULL
infection	NULL
increases	NULL
the	NULL
synthesis	NULL
of	NULL
host	NULL
DNA	NULL
,	NULL
RNA	NULL
,	NULL
and	NULL
protein	NULL
(	NULL
21	NULL
,	NULL
23	NULL
)	NULL
,	NULL
and	NULL
CMV-infected	NULL
cells	NULL
show	NULL
an	NULL
initial	NULL
decrease	NULL
in	NULL
protein	NULL
synthesis	NULL
,	NULL
followed	NULL
by	NULL
its	NULL
significant	NULL
increase	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
UV-irradiated	NULL
virus	NULL
causes	NULL
an	NULL
initial	NULL
decrease	NULL
in	NULL
protein	NULL
synthesis	NULL
without	NULL
its	NULL
subsequent	NULL
increase	NULL
.	NULL

Hence	NULL
,	NULL
stimulation	NULL
of	NULL
host	NULL
cell	NULL
protein	NULL
synthesis	NULL
by	NULL
CMV	NULL
at	NULL
the	NULL
later	NULL
phase	NULL
appears	NULL
to	NULL
require	NULL
the	NULL
synthesis	NULL
of	NULL
a	NULL
virally	NULL
encoded	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
failure	NULL
of	NULL
UV-irradiated	NULL
CMV	NULL
to	NULL
induce	NULL
IL-8	NULL
production	NULL
suggests	NULL
that	NULL
CMV	NULL
caused	NULL
IL-8	NULL
production	NULL
by	NULL
de	NULL
novo	NULL
synthesis	NULL
of	NULL
a	NULL
virally	NULL
encoded	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
.	NULL

Accumulating	NULL
evidence	NULL
indicates	NULL
that	NULL
CMV	NULL
infection	NULL
arrests	NULL
at	NULL
the	NULL
stage	NULL
of	NULL
the	NULL
IE	NULL
gene	NULL
expression	NULL
in	NULL
monocytic	NULL
cells	NULL
including	NULL
THP-1	NULL
cells	NULL
(	NULL
17	NULL
,	NULL
20	NULL
,	NULL
25	NULL
)	NULL
.	NULL

The	NULL
transcription	NULL
of	NULL
IL-1B	NULL
was	NULL
significantly	NULL
enhanced	NULL
by	NULL
the	NULL
transfection	NULL
with	NULL
the	NULL
IE1	NULL
gene	NULL
but	NULL
not	NULL
the	NULL
IE2	NULL
gene	NULL
of	NULL
CMV	NULL
(	NULL
7	NULL
)	NULL
,	NULL
whereas	NULL
that	NULL
of	NULL
an	NULL
IL-1-related	NULL
cytokine	NULL
,	NULL
IL-1	NULL
receptor	NULL
antagonist	NULL
,	NULL
was	NULL
enhanced	NULL
by	NULL
the	NULL
transfection	NULL
with	NULL
the	NULL
IE2	NULL
gene	NULL
but	NULL
not	NULL
the	NULL
IE1	NULL
gene	NULL
(	NULL
10	NULL
)	NULL
.	NULL

It	NULL
remains	NULL
to	NULL
be	NULL
investigated	NULL
whether	NULL
these	NULL
IE	NULL
gene	NULL
products	NULL
are	NULL
involved	NULL
in	NULL
IL-8	NULL
gene	NULL
expression	NULL
.	NULL

The	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
but	NULL
neither	NULL
AP-1	NULL
nor	NULL
NF-IL-6	NULL
was	NULL
indispensable	NULL
for	NULL
LPS-induced	NULL
IL-8	NULL
gene	NULL
transcription	NULL
in	NULL
THP	NULL
cells	NULL
(	NULL
6	NULL
)	NULL
.	NULL

However	NULL
,	NULL
our	NULL
present	NULL
results	NULL
demonstrate	NULL
that	NULL
the	NULL
activation	NULL
of	NULL
AP-1	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
but	NULL
not	NULL
that	NULL
of	NULL
NF-IL-6	NULL
was	NULL
indispensable	NULL
for	NULL
CMV-induced	NULL
IL-8	NULL
gene	NULL
transcription	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
molecular	NULL
mechanism	NULL
involved	NULL
in	NULL
IL-8	NULL
gene	NULL
transcription	NULL
differed	NULL
,	NULL
even	NULL
within	NULL
the	NULL
same	NULL
cell	NULL
,	NULL
depending	NULL
on	NULL
the	NULL
employed	NULL
stimuli	NULL
.	NULL

We	NULL
demonstrated	NULL
that	NULL
IL-8	NULL
enhanced	NULL
CMV	NULL
replication	NULL
in	NULL
lung	NULL
fibroblasts	NULL
and	NULL
that	NULL
CMV	NULL
infection	NULL
induced	NULL
IL-8	NULL
receptor	NULL
expression	NULL
on	NULL
these	NULL
cells	NULL
(	NULL
14	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
CMV	NULL
infection	NULL
induces	NULL
inflammatory	NULL
reactions	NULL
through	NULL
interacting	NULL
with	NULL
IL-8	NULL
and	NULL
its	NULL
receptors	NULL
.	NULL

We	NULL
further	NULL
demonstrated	NULL
here	NULL
that	NULL
CMV	NULL
infection	NULL
induced	NULL
in	NULL
vitro	NULL
IL-8	NULL
production	NULL
by	NULL
peripheral	NULL
blood	NULL
MNC	NULL
as	NULL
well	NULL
as	NULL
THP-1	NULL
cells	NULL
.	NULL

Since	NULL
infectious	NULL
CMV	NULL
induced	NULL
in	NULL
vitro	NULL
IL-8	NULL
production	NULL
by	NULL
additional	NULL
types	NULL
of	NULL
human	NULL
cells	NULL
,	NULL
including	NULL
lung	NULL
fibroblasts	NULL
and	NULL
astrocytoma	NULL
cells	NULL
(	NULL
our	NULL
unpublished	NULL
data	NULL
)	NULL
,	NULL
it	NULL
is	NULL
probable	NULL
that	NULL
,	NULL
even	NULL
in	NULL
vivo	NULL
,	NULL
CMV	NULL
induces	NULL
various	NULL
types	NULL
of	NULL
cells	NULL
to	NULL
produce	NULL
IL-8	NULL
.	NULL

The	NULL
reactivation	NULL
of	NULL
persistent	NULL
or	NULL
latent	NULL
infection	NULL
causes	NULL
overt	NULL
CMV	NULL
infection	NULL
in	NULL
AIDS	NULL
patients	NULL
and	NULL
immunocompromised	NULL
recipients	NULL
of	NULL
organ	NULL
transplants	NULL
(	NULL
1	NULL
,	NULL
15	NULL
)	NULL
.	NULL

CMV	NULL
infection	NULL
in	NULL
vitro	NULL
induced	NULL
a	NULL
rapid	NULL
production	NULL
of	NULL
massive	NULL
amounts	NULL
of	NULL
IL-8	NULL
.	NULL

We	NULL
observed	NULL
that	NULL
IL-8	NULL
enhanced	NULL
in	NULL
vitro	NULL
CMV	NULL
replication	NULL
in	NULL
lung	NULL
fibroblasts	NULL
(	NULL
14	NULL
)	NULL
and	NULL
that	NULL
IL-8	NULL
in	NULL
vitro	NULL
antagonized	NULL
the	NULL
antiviral	NULL
activity	NULL
of	NULL
IFN	NULL
and	NULL
enhanced	NULL
picornavirus	NULL
replication	NULL
through	NULL
reducing	NULL
both	NULL
virus-induced	NULL
and	NULL
constitutive	NULL
2	NULL
,	NULL
5	NULL
A-synthetase	NULL
activities	NULL
(	NULL
9	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
IL-8	NULL
produced	NULL
upon	NULL
CMV	NULL
infection	NULL
may	NULL
aggravate	NULL
CMV	NULL
infection	NULL
by	NULL
enhancing	NULL
virus	NULL
replication	NULL
and	NULL
counteracting	NULL
the	NULL
antiviral	NULL
activities	NULL
of	NULL
IFN	NULL
.	NULL

In	NULL
such	NULL
cases	NULL
,	NULL
IL-8	NULL
might	NULL
be	NULL
a	NULL
novel	NULL
target	NULL
for	NULL
intervention	NULL
therapy	NULL
for	NULL
opportunistic	NULL
CMV	NULL
infection	NULL
and	NULL
CMV-associated	NULL
diseases	NULL
.	NULL

We	NULL
express	NULL
our	NULL
gratitude	NULL
to	NULL
N.	NULL
R.	NULL
Rice	NULL
for	NULL
providing	NULL
us	NULL
with	NULL
antisera	NULL
to	NULL
Rel-related	NULL
proteins	NULL
and	NULL
to	NULL
Charles	NULL
R.	NULL
Rinaldo	NULL
,	NULL
Jr.	NULL
,	NULL
for	NULL
critical	NULL
review	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
W.	NULL
Yoneda	NULL
for	NULL
technical	NULL
assistance	NULL
.	NULL

This	NULL
work	NULL
is	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
grants-in-aid	NULL
from	NULL
the	NULL
Ministry	NULL
of	NULL
Education	NULL
,	NULL
Culture	NULL
,	NULL
and	NULL
Science	NULL
in	NULL
Japan	NULL
and	NULL
from	NULL
the	NULL
Core	NULL
Research	NULL
for	NULL
Evolutional	NULL
Science	NULL
and	NULL
Technology	NULL
.	NULL

Vor	NULL
.	NULL

71	NULL
,	NULL
1997	NULL
10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

REFERENCES	NULL
.	NULL

Alford	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
Britt	NULL
.	NULL

1990	NULL
.	NULL

Cytomegalovirus	NULL
,	NULL
p.	NULL
1981-2010.	NULL
in	NULL
B.	NULL
N.	NULL
Fields	NULL
and	NULL
D.	NULL
M.	NULL
Knipe	NULL
(	NULL
ed	NULL
.	NULL
)	NULL

,	NULL
Fields	NULL
Virology	NULL
,	NULL
2nd	NULL
ed	NULL
.	NULL

Raven	NULL
Press	NULL
,	NULL
Ltd.	NULL
,	NULL
New	NULL
York	NULL
,	NULL
N.Y.	NULL
.	NULL

Carney	NULL
,	NULL
W.	NULL
P.	NULL
,	NULL
and	NULL
M.	NULL
S.	NULL
Hirsch	NULL
.	NULL

1981	NULL
.	NULL

Mechanisms	NULL
of	NULL
immunosuppression	NULL
in	NULL
cytomegalovirus	NULL
mononucleosis	NULL
.	NULL

II	NULL
.	NULL

Virus-monocyte	NULL
interactions	NULL
.	NULL

J.	NULL
Infect	NULL
.	NULL

Dis	NULL
.	NULL

144:47-54.	NULL
.	NULL

Dignam	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
R.	NULL
M.	NULL
Lebovitze	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roever	NULL
.	NULL

1983	NULL
.	NULL

Accurate	NULL
transcrip-	NULL
tion	NULL
initiation	NULL
by	NULL
RNA	NULL
polymerase	NULL
II	NULL
in	NULL
a	NULL
soluble	NULL
extract	NULL
from	NULL
isolated	NULL
mammalian	NULL
nuclei	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

11:1475-1489.	NULL
.	NULL

Furukawa	NULL
,	NULL
T.	NULL
,	NULL
A.	NULL
Fioretti	NULL
,	NULL
and	NULL
S.	NULL
A.	NULL
Plotkin	NULL
.	NULL

1973	NULL
.	NULL

Growth	NULL
characteristics	NULL
of	NULL
cytomegalovirus	NULL
in	NULL
human	NULL
fibroblasts	NULL
with	NULL
demonstration	NULL
of	NULL
protein	NULL
synthesis	NULL
early	NULL
in	NULL
viral	NULL
replication	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

11:991-997.	NULL
.	NULL

Harada	NULL
,	NULL
A.	NULL
,	NULL
N.	NULL
Sekido	NULL
,	NULL
K.	NULL
Kuno	NULL
,	NULL
M.	NULL
Akiyama	NULL
,	NULL
T.	NULL
Kasahara	NULL
,	NULL
I	NULL
Nakanishi	NULL
,	NULL
N.	NULL
Mukaida	NULL
,	NULL
and	NULL
M.	NULL
Matsushima	NULL
.	NULL

1993	NULL
.	NULL

Expression	NULL
of	NULL
recombinant	NULL
rabbit	NULL
IL-8	NULL
in	NULL
Escherichia	NULL
coli	NULL
and	NULL
establishment	NULL
of	NULL
the	NULL
essential	NULL
involvement	NULL
of	NULL
IL-8	NULL
in	NULL
recruiting	NULL
neutrophils	NULL
into	NULL
lipopolysaccharide-induced	NULL
inflammatory	NULL
site	NULL
of	NULL
rabbit	NULL
skin	NULL
.	NULL

Int	NULL
.	NULL

Immunol	NULL
.	NULL

5:681-690.	NULL
.	NULL

Ishikawa	NULL
,	NULL
Y.	NULL
,	NULL
N.	NULL
Mukaida	NULL
,	NULL
K.	NULL
Kuno	NULL
,	NULL
N.	NULL
Rice	NULL
,	NULL
S.	NULL
Okamoto	NULL
,	NULL
and	NULL
K.	NULL
Matsu-	NULL
shima	NULL
.	NULL

1995	NULL
.	NULL

Establishment	NULL
of	NULL
lipopolysaccharide-dependent	NULL
nuclear	NULL
factor	NULL
xB	NULL
activation	NULL
in	NULL
a	NULL
cell-free	NULL
system	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:4158-4164.	NULL
.	NULL

Iwamota	NULL
,	NULL
G.	NULL
K.	NULL
,	NULL
M.	NULL
M.	NULL
Monick	NULL
,	NULL
B.	NULL
D.	NULL
Clark	NULL
,	NULL
P.	NULL
E.	NULL
Auron	NULL
,	NULL
M.	NULL
F.	NULL
Stinski	NULL
,	NULL
and	NULL
G.	NULL
W.	NULL
Hunninghake	NULL
.	NULL

1990	NULL
.	NULL

Modulation	NULL
of	NULL
interleukin	NULL
1	NULL
beta	NULL
gene	NULL
expression	NULL
by	NULL
the	NULL
immediate	NULL
early	NULL
genes	NULL
of	NULL
human	NULL
cytomegalovirus	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

85:1853-1857.	NULL
.	NULL

Jacobs	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
C.	NULL
M.	NULL
Jones	NULL
,	NULL
and	NULL
J.	NULL
P.	NULL
Belle	NULL
.	NULL

1970	NULL
.	NULL

Characteristics	NULL
of	NULL
a	NULL
diploid	NULL
cell	NULL
designated	NULL
MRC-5	NULL
.	NULL

Nature	NULL
227:168-173.	NULL
.	NULL

Khabar	NULL
,	NULL
K.	NULL
S.	NULL
A.	NULL
,	NULL
F.	NULL
Al-Zoghaibi	NULL
,	NULL
M.	NULL
Taba	NULL
,	NULL
and	NULL
M.	NULL
Al-Abdal	NULL
.	NULL

1996	NULL
.	NULL

A	NULL
proviral	NULL
action	NULL
for	NULL
interleukin-8	NULL
:	NULL
IL-8	NULL
enhances	NULL
viral	NULL
replication	NULL
and	NULL
antagonizes	NULL
interferon	NULL
(	NULL
IFN	NULL
)	NULL
antiviral	NULL
action	NULL
.	NULL

Eur	NULL
.	NULL

Cytokine	NULL
Netw	NULL
.	NULL

7:554	NULL
.	NULL

Kline	NULL
,	NULL
J.	NULL
N.	NULL
,	NULL
L.	NULL
J.	NULL
Geist	NULL
,	NULL
M.	NULL
M.	NULL
Monick	NULL
,	NULL
M.	NULL
F.	NULL
Stinski	NULL
,	NULL
and	NULL
G.	NULL
W.	NULL
Hunninghake	NULL
.	NULL

1994	NULL
.	NULL

Regulation	NULL
of	NULL
expression	NULL
of	NULL
the	NULL
IL-1	NULL
receptor	NULL
antagonist	NULL
(	NULL
IL-1ra	NULL
)	NULL
gene	NULL
by	NULL
products	NULL
of	NULL
the	NULL
human	NULL
cytomegalovirus	NULL
immediate	NULL
carly	NULL
genes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

152:2351-2357	NULL
.	NULL

Ko	NULL
,	NULL
Y.	NULL
,	NULL
N.	NULL
Mukaida	NULL
,	NULL
A.	NULL
Pamyutich	NULL
,	NULL
N.	NULL
N.	NULL
Voitenk	NULL
,	NULL
K.	NULL
Matsushima	NULL
,	NULL
T.	NULL
Kawai	NULL
,	NULL
and	NULL
T.	NULL
Kasahara	NULL
.	NULL

1992	NULL
.	NULL

Establishment	NULL
of	NULL
a	NULL
sensitive	NULL
enzyme-linked	NULL
immunosorbent	NULL
assay	NULL
for	NULL
human	NULL
interleukin	NULL
8	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

Methods	NULL
149:227-235	NULL
.	NULL

Mukaida	NULL
,	NULL
N.	NULL
,	NULL
M.	NULL
Morita	NULL
,	NULL
Y.	NULL
Ishikawa	NULL
,	NULL
N.	NULL
Rice	NULL
,	NULL
S.	NULL
Okamoto	NULL
,	NULL
T.	NULL
Kasahara	NULL
,	NULL
and	NULL
K.	NULL
Matsushima	NULL
.	NULL

1994	NULL
.	NULL

Novel	NULL
mechanism	NULL
of	NULL
glucocorticoid-mediated	NULL
gene	NULL
replication	NULL
.	NULL

Nuclear	NULL
factor-	NULL
«	NULL
kB	NULL
is	NULL
target	NULL
for	NULL
glucocorticoid-mediated	NULL
interleukin	NULL
8	NULL
gene	NULL
replication	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:13289-13295	NULL
.	NULL

Mulligan	NULL
,	NULL
M.	NULL
S.	NULL
,	NULL
M.	NULL
L.	NULL
Jones	NULL
,	NULL
M.	NULL
A.	NULL
Bol	NULL
ki	NULL
,	NULL
M.	NULL
P.	NULL
Baganoff	NULL
,	NULL
C.	NULL
L.	NULL
Deppeler	NULL
,	NULL
D.	NULL
M.	NULL
Meyers	NULL
,	NULL
U.	NULL
S.	NULL
Ryan	NULL
,	NULL
and	NULL
P.	NULL
A	NULL
.	NULL

Ward	NULL
.	NULL

1993	NULL
.	NULL

Inhibition	NULL
of	NULL
lung	NULL
inflammatory	NULL
15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

NOTES	NULL
-	NULL
5695	NULL
reactions	NULL
in	NULL
rats	NULL
by	NULL
an	NULL
anti-human	NULL
IL-8	NULL
antibody	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

150:5585-5595.	NULL
.	NULL

Murayama	NULL
,	NULL
T.	NULL
,	NULL
K.	NULL
Kuno	NULL
,	NULL
F.	NULL
Jisaki	NULL
,	NULL
M.	NULL
Obuchi	NULL
,	NULL
D.	NULL
Sakamuro	NULL
,	NULL
T.	NULL
Furukawa	NULL
,	NULL
N.	NULL
Mukaida	NULL
,	NULL
and	NULL
K.	NULL
Matsushima	NULL
.	NULL

1994	NULL
.	NULL

Enhancement	NULL
of	NULL
human	NULL
cytomegalovirus	NULL
replication	NULL
in	NULL
a	NULL
human	NULL
lung	NULL
fibroblast	NULL
cell	NULL
line	NULL
by	NULL
interleukin-8	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

68:7582-7585	NULL
.	NULL

Nelson	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
C.	NULL
Reynolds-Kohler	NULL
,	NULL
M.	NULL
B	NULL
.	NULL

A.	NULL
Oldstone	NULL
,	NULL
and	NULL
C.	NULL
A.	NULL
Wiley	NULL
.	NULL

1988	NULL
.	NULL

HIV	NULL
and	NULL
HCMV	NULL
coinfection	NULL
in	NULL
brain	NULL
cells	NULL
in	NULL
patients	NULL
with	NULL
AIDS	NULL
.	NULL

Virology	NULL
165:286-290	NULL
.	NULL

Okamoto	NULL
,	NULL
S.	NULL
,	NULL
N.	NULL
Mukaida	NULL
,	NULL
K.	NULL
Yasumoto	NULL
,	NULL
N.	NULL
Rice	NULL
,	NULL
Y.	NULL
Ishikawa	NULL
,	NULL
H.	NULL
Horiguchi	NULL
,	NULL
S.	NULL
Murakami	NULL
,	NULL
and	NULL
K.	NULL
Matsushima	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
interleukin-8	NULL
AP-1	NULL
and	NULL
«	NULL
B-like	NULL
sites	NULL
are	NULL
genetic	NULL
end	NULL
targets	NULL
of	NULL
FK-506-sensitive	NULL
pathway	NULL
accompanied	NULL
by	NULL
calcium	NULL
mobilization	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:8582-8589	NULL
.	NULL

Rice	NULL
,	NULL
G.	NULL
P.	NULL
A.	NULL
,	NULL
R.	NULL
D.	NULL
Schrier	NULL
,	NULL
and	NULL
M.	NULL
B	NULL
.	NULL

A.	NULL
Oldstone	NULL
.	NULL

1984	NULL
.	NULL

Cytomegalovirus	NULL
infects	NULL
human	NULL
lymphocytes	NULL
and	NULL
monocytes	NULL
:	NULL
Virus	NULL
expression	NULL
is	NULL
restricted	NULL
to	NULL
immediate-early	NULL
gene	NULL
products	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
81:6134-6138	NULL
.	NULL

Rice	NULL
,	NULL
N.	NULL
R.	NULL
,	NULL
M.	NULL
L.	NULL
Mackichan	NULL
,	NULL
and	NULL
A.	NULL
Israel	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
precursor	NULL
of	NULL
NF-kB	NULL
p50	NULL
has	NULL
IxB-like	NULL
functions	NULL
.	NULL

Cell	NULL
71:243-253	NULL
.	NULL

Sekido	NULL
,	NULL
N.	NULL
,	NULL
N.	NULL
Mukaida	NULL
,	NULL
A.	NULL
Harada	NULL
,	NULL
I.	NULL
Nakanishi	NULL
,	NULL
Y.	NULL
Watanaba	NULL
,	NULL
and	NULL
K.	NULL
Matsushima	NULL
.	NULL

1993	NULL
.	NULL

Prevention	NULL
of	NULL
lung	NULL
reperfusion	NULL
injury	NULL
in	NULL
rabbits	NULL
by	NULL
a	NULL
monoclonal	NULL
antibody	NULL
against	NULL
interleukin-8	NULL
.	NULL

Nature	NULL
365:654-657	NULL
.	NULL

Sinclair	NULL
,	NULL
J.	NULL
H.	NULL
,	NULL
J.	NULL
Baillie	NULL
,	NULL
L.	NULL
A.	NULL
Bryant	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Taylor-Wiedeman	NULL
,	NULL
and	NULL
J.	NULL
G.	NULL
P.	NULL
Sissons	NULL
.	NULL

1992	NULL
.	NULL

Repression	NULL
of	NULL
human	NULL
cytomegalovirus	NULL
major	NULL
immediate	NULL
carly	NULL
gene	NULL
expression	NULL
in	NULL
a	NULL
monocytic	NULL
cell	NULL
line	NULL
.	NULL

J.	NULL
Gen.	NULL
Virol	NULL
.	NULL

73:433-435	NULL
.	NULL

St.	NULL
Jeor	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
T.	NULL
B.	NULL
Albrecht	NULL
,	NULL
F.	NULL
D.	NULL
Funk	NULL
,	NULL
and	NULL
F.	NULL
Rapp	NULL
.	NULL

1974	NULL
.	NULL

Stimulation	NULL
of	NULL
cellular	NULL
DNA	NULL
synthesis	NULL
by	NULL
human	NULL
cytomegalovirus	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

13:353-362	NULL
.	NULL

Tan	NULL
,	NULL
T.-H.	NULL
,	NULL
G.	NULL
P.	NULL
Huang	NULL
,	NULL
A.	NULL
Sica	NULL
,	NULL
P.	NULL
Ghosh	NULL
,	NULL
H.	NULL
A	NULL
.	NULL

Young	NULL
,	NULL
D.	NULL
L.	NULL
Longo	NULL
,	NULL
and	NULL
N.	NULL
R.	NULL
Rice	NULL
.	NULL

1992	NULL
.	NULL

«	NULL
B	NULL
site-dependent	NULL
activation	NULL
of	NULL
the	NULL
interleukin-2	NULL
receptor	NULL
alpha-chain	NULL
gene	NULL
promoter	NULL
by	NULL
human	NULL
c-Rel	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:4067-4075	NULL
.	NULL

Tanaka	NULL
,	NULL
S.	NULL
,	NULL
T.	NULL
Furukawa	NULL
,	NULL
and	NULL
S.	NULL
A.	NULL
Plotkin	NULL
.	NULL

1975	NULL
.	NULL

Human	NULL
cytomegalovirus-stimulated	NULL
host	NULL
cell	NULL
DNA	NULL
synthesis	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

15:297-304	NULL
.	NULL

Tsuchiya	NULL
,	NULL
S.	NULL
,	NULL
M.	NULL
Yamabe	NULL
,	NULL
Y.	NULL
Yamaguchi	NULL
,	NULL
Y.	NULL
Kobayashi	NULL
,	NULL
T.	NULL
Konno	NULL
,	NULL
and	NULL
K.	NULL
Tada	NULL
.	NULL

1980	NULL
.	NULL

Establishment	NULL
and	NULL
characterization	NULL
of	NULL
a	NULL
human	NULL
acute	NULL
monocytic	NULL
leukemia	NULL
cell	NULL
line	NULL
(	NULL
THP-1	NULL
)	NULL
.	NULL

Int	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
26:171-176.	NULL
.	NULL

Turtinen	NULL
,	NULL
L.	NULL
W.	NULL
,	NULL
A.	NULL
Assimacopoulos	NULL
,	NULL
and	NULL
A.	NULL
T.	NULL
Haase	NULL
.	NULL

1989	NULL
.	NULL

Increased	NULL
mono	NULL
kines	NULL
in	NULL
cytomegalovirus	NULL
infected	NULL
myelomonocytic	NULL
cell	NULL
cultures	NULL
.	NULL

Microb	NULL
.	NULL

Pathog	NULL
.	NULL

7:135-145	NULL
.	NULL

Wentworth	NULL
,	NULL
B	NULL
.	NULL

B.	NULL
,	NULL
and	NULL
L.	NULL
French	NULL
.	NULL

1970	NULL
.	NULL

Plaque	NULL
assay	NULL
of	NULL
cytomegalovirus	NULL
strain	NULL
of	NULL
human	NULL
origin	NULL
.	NULL

Proc	NULL
.	NULL

Soc	NULL
.	NULL

Exp	NULL
.	NULL

Biol	NULL
.	NULL

Med	NULL
.	NULL

135:253-258	NULL
.	NULL

Yasumoto	NULL
,	NULL
K.	NULL
,	NULL
S.	NULL
Okamoto	NULL
,	NULL
N.	NULL
Mukaida	NULL
,	NULL
S.	NULL
Murakami	NULL
,	NULL
M.	NULL
Mai	NULL
,	NULL
and	NULL
K.	NULL
Matsushima	NULL
.	NULL

1992	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
and	NULL
interferon	NULL
gamma	NULL
syn-ergistically	NULL
induce	NULL
interleukin	NULL
8	NULL
production	NULL
in	NULL
a	NULL
human	NULL
gastric	NULL
cancer	NULL
cell	NULL
line	NULL
through	NULL
acting	NULL
concurrently	NULL
on	NULL
AP-1	NULL
and	NULL
NF-B-like	NULL
binding	NULL
sites	NULL
of	NULL
the	NULL
interleukin	NULL
8	NULL
gene	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267:22506-22511	NULL
.	NULL

